Androgens and Breast Tumors: The Role of PSA and GCDFP-15
Author Information
Author(s): RE Hall, JA Clements, SN Birrell, WD Tilley
Primary Institution: Flinders University of South Australia
Hypothesis
The study investigates the relationship between androgen receptor status and the expression of prostate-specific antigen (PSA) and gross cystic disease fluid protein-15 (GCDFP-15) in primary breast tumors.
Conclusion
PSA and GCDFP-15 expression in breast tumors is dependent on the presence of androgen receptors, but not on estrogen or progesterone receptor status.
Supporting Evidence
- 85% of breast tumors were found to be AR-positive.
- 98% of PSA-positive tumors were also AR-positive.
- PSA immunoreactivity was significantly associated with GCDFP-15 immunoreactivity.
Takeaway
This study found that certain proteins related to androgens are present in many breast tumors, which might help doctors understand how to treat these cancers better.
Methodology
The study used immunohistochemistry to examine the expression of androgen receptors, PSA, and GCDFP-15 in 72 primary breast tumors.
Limitations
The study did not determine tumor grade in five cases and had a relatively small sample size.
Participant Demographics
Median age at operation was 59 years, with a range from 30 to 86 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website